[Vitamin Kl, its therapeutic indications]. 1961

D ALAGILLE

UI MeSH Term Description Entries
D000933 Antifibrinolytic Agents Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. Antifibrinolysin,Antifibrinolysins,Antifibrinolytic,Antifibrinolytic Agent,Antiplasmin,Antiplasmins,Antifibrinolytics,Plasmin Inhibitor,Plasmin Inhibitors,Agent, Antifibrinolytic,Agents, Antifibrinolytic,Inhibitor, Plasmin,Inhibitors, Plasmin
D014812 Vitamin K A lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 (phytomenadione) derived from plants, VITAMIN K 2 (menaquinone) from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 (menadione). Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.
D014815 Vitamins Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. Vitamin

Related Publications

D ALAGILLE
February 1951, Vie medicale (Paris, France : 1920),
D ALAGILLE
January 1949, Medicina practica,
D ALAGILLE
October 1973, Medizinische Monatsschrift,
D ALAGILLE
January 1958, Semaine medicale professionelle et medico-sociale,
D ALAGILLE
November 1955, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
D ALAGILLE
January 1947, Revue medicale de Nancy,
Copied contents to your clipboard!